Article
Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis.
International journal of dermatology - 1 Apr 2016
Xu Yang, Wang Wenling, Tian Yanli, Liu Jingyang, Yang Rongya
Abstract excerpt
BACKGROUND: Systemic sclerosis (SSc) is the most severe connective tissue disorder. Recent studies have demonstrated that genetic factors may play a role in the development of SSc. The aim of this study was to investigate the association of signal transducer and activator of transcription 4 (STAT4) rs7574865 and interferon regulatory factor 5 (IRF5) rs2004640 polymorphisms with risk of SSc. METHODS: Case-control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
